ArticleScientific reports2026
Prognostic value of desmoplastic growth patterns in resected hepatocellular carcinoma.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic value of desmoplastic growth patterns in resected hepatocellular carcinoma.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prognostic value of histopathological growth patterns is well established in liver metastases, but their significance in hepatocellular carcinoma (HCC) remains uncertain. This study examined the prognostic relevance of the desmoplastic HGP (dHGP) in HCC and explored the impact of the degree of desmoplasia using three assessment methods. We retrospectively analysed 99 patients resected for HCC at two Finnish centres; 74 had adequate tissue for evaluation. HGP was classified as uniform dHGP (44/74) or predominant dHGP (66/74). The degree of desmoplasia was visually estimated as the minimum, maximum, and average distance between tumour cells and adjacent liver parenchyma. Uniform dHGP was not associated with survival in multivariable analysis. Predominant dHGP independently predicted improved overall survival (HR 0.15, 95% CI 0.04-0.51, P = 0.003) and disease-specific survival (HR 0.16, 95% CI 0.04-0.73, P = 0.018). Stronger desmoplasia was associated with improved disease-specific survival across all evaluation methods in multivariable analyses. Uniform and predominant dHGP may be associated with more favourable long-term outcomes in resected HCC, although further investigation is needed, particularly given the small sample size in the predominant non-dHGP group. We present three methods to quantify desmoplasia, providing a basis for future clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.